2,4-Piperadinedione

2,4-Piperadinedione Suppliers list
Company Name: Tianjin Scaxchem Limited Compnay  Gold
Tel: 18630949181
Email: sales@cosychem.com
Company Name: Ningbo yirui biology science and technology co., ltd  Gold
Tel: 15221000252
Email: 278450236@qq.com
Company Name: Shanghai Hobor Chemical Co., Ltd  Gold
Tel: 13918007836
Email: sales@hoborchem.com
Company Name: Accela ChemBio Co.,Ltd.  Gold
Tel: 021-50795510 4000665055
Email: marketing@accelachem.com
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com

2,4-Piperadinedione manufacturers

2,4-Piperadinedione Basic information
Product Name:2,4-Piperadinedione
Synonyms:piperidine-2,4-dione, dihydropyridine-4,6-dione, 2,4-dioxopiperidine, 2,4-piperidinedione, piperidin-2,4-dione, 2,4-diketopiperidine, Piperidine-2,4-dione;2,4-PiperadinedioneE;Piperidine-2,4-dione 97%;2,4-PIPERADINEDIONE;PIPERIDIN-2,4-DIONE;dihydropyridine-4,6-dione;2,4-Dioxopiperidine;2,4-Piperidinedione, 95+%
CAS:50607-30-2
MF:C5H7NO2
MW:113.11
EINECS:803-771-9
Product Categories:Pharmaceutical intermediate;Heterocycles series
Mol File:50607-30-2.mol
2,4-Piperadinedione Structure
2,4-Piperadinedione Chemical Properties
Melting point 98.0 to 102.0 °C
Boiling point 362.1±35.0 °C(Predicted)
density 1.184±0.06 g/cm3(Predicted)
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
form powder to crystal
pka12.00±0.70(Predicted)
color White to Orange to Green
InChIInChI=1S/C5H7NO2/c7-4-1-2-6-5(8)3-4/h1-3H2,(H,6,8)
InChIKeyRDNZDMDLRIQQAX-UHFFFAOYSA-N
SMILESN1CCC(=O)CC1=O
Safety Information
Hazard Codes Xn
Risk Statements 22-36/37/38-43
Safety Statements 26-36/37
RIDADR UN 3335
WGK Germany 3
HS Code 2933790090
Storage Class11 - Combustible Solids
Hazard ClassificationsAcute Tox. 4 Oral
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
STOT SE 3
MSDS Information
2,4-Piperadinedione Usage And Synthesis
Description2,4-Piperidinedione is an important piperidine ring-containing intermediate, and its 2,4-piperidinedione, as a characteristic fragment, is widely used as an intermediate in the synthesis of ibrutinib and paliperidone drugs.
Chemical PropertiesWhite to light yellow solid
Uses2,4-Piperidinedione is a reactant in the synthesis of 1,4-dihydropyridines as TGFβ/Smad inhibitors.
PreparationThe synthesis of 2,4-Piperidinedione involved dissolving 400 mg (2.34 mmol, 1.00 eq.) of Methyl 2,4-dioxo-piperidine-3-carboxylate in a mixture of acetonitrile (20 mL) and water (0.2 mL). The solution was then heated to approximately 86° C. and maintained at this temperature for around 4 hours. After completion of the reaction, the solvent was removed under vacuum, leaving behind a residue of 2,4-Piperidinedione. This residue was further purified using silica gel column chromatography with a mobile phase consisting of dichloromethane and methanol in a ratio of 100:1. The target product, 2,4-Piperidinedione, was obtained as a white solid, with a yield of 27%, corresponding to 70 mg.
Synthesis
TERT-BUTYL 2,4-DIOXOPIPERIDINE-1-CARBOXYLATE

845267-78-9

2,4-Piperadinedione

50607-30-2

The general procedure for the synthesis of 2,4-piperidinediones from tert-butyl 2,4-dipiperidone-1-carboxylate was as follows: at 0 °C and under nitrogen protection, Boc-β-alanine (25 g, 132 mmol), Meldrum acid (20.9 g, 145 mmol), and 4-dimethylaminopyridine (DMAP, 24.2 g, 198 mmol) were dissolved in 700 mL of anhydrous dichloromethane (DCM). To this solution was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI, 30.4 g, 158 mmol). The reaction mixture was slowly warmed to room temperature and stirred overnight. After completion of the reaction, the reaction mixture was washed with 5% KHSO4 aqueous solution (0.5 L x 4). The organic layer was dried with anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give the crude product [tert-butyl [3-(2,2-dimethyl-4,6-dioxo-[1,3]dioxol-5-yl)-3-oxo-propyl]-carbamate. The crude product was dissolved in 600 mL of ethyl acetate and refluxed for 4 hours. It was concentrated under reduced pressure to a volume of about 150 mL and subsequently crystallized at 4°C overnight. The solid was collected by filtration and washed with cold ethyl acetate to afford 18.4 g (65% yield) of 2,4-piperidinedione.1H NMR (400 MHz, DMSO-D6) δppm: 1.44 (s, 9H), 2.44 (m, 2H), 3.71 (m, 2H), 4.95 (s, 1H), 11.2 (bs, 1H). The resulting product was converted quantitatively to piperidine-2,4-dione by dissolving in dichloromethane and treating with trifluoroacetic acid for 3 h at room temperature.

References[1] Patent: WO2008/104475, 2008, A1. Location in patent: Page/Page column 22
[2] Patent: WO2012/35078, 2012, A1. Location in patent: Page/Page column 144
[3] Patent: US2014/45872, 2014, A1. Location in patent: Paragraph 0911
[4] Journal of Medicinal Chemistry, 2008, vol. 51, # 3, p. 487 - 501
[5] Angewandte Chemie - International Edition, 2014, vol. 53, # 14, p. 3594 - 3598
Tag:2,4-Piperadinedione(50607-30-2) Related Product Information
DROPERIDOL Haloperidol 2',4'-Dichloroacetophenone Triacetonediamine 2,2,6,6-Tetramethyl-4-piperidinol Diphenoxylate METHYPRYLON 1-benzylpiperidine-3,5-dione Ethyl 4-(4,4-dimethyl-2,6-dioxopiperidin-1-yl)benzoate Aminoglutethimide 2,6-Dioxopiperidine-3-ammonium chloride DL-Glutethimide Antineoplaston A10 N-Benzyl-2,6-piperidinedion 6-Phenylazaperhydroine-2,4-dione 3,3-Dimethylglutarimide 5-Ethyl-2,4-piperidinedione 3-Ethyl-3-methylglutarimide